Deutsche Bank’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Sell |
42,967
-17,296
| -29% | -$62.3K | ﹤0.01% | 3065 |
|
|
2025
Q1 | $180K | Buy |
+60,263
| New | +$180K | ﹤0.01% | 2977 |
|
|
2024
Q4 | – | Sell |
-49,567
| Closed | -$166K | – | 3542 |
|
|
2024
Q3 | $166K | Buy |
49,567
+17,118
| +53% | +$57.3K | ﹤0.01% | 2966 |
|
|
2024
Q2 | $107K | Sell |
32,449
-7,941
| -20% | -$26.3K | ﹤0.01% | 3051 |
|
|
2024
Q1 | $163K | Buy |
40,390
+1,915
| +5% | +$7.74K | ﹤0.01% | 2902 |
|
|
2023
Q4 | $117K | Sell |
38,475
-1,847
| -5% | -$5.63K | ﹤0.01% | 3101 |
|
|
2023
Q3 | $121K | Buy |
40,322
+3,003
| +8% | +$9.01K | ﹤0.01% | 3040 |
|
|
2023
Q2 | $140K | Sell |
37,319
-19,887
| -35% | -$74.4K | ﹤0.01% | 3084 |
|
|
2023
Q1 | $192K | Buy |
57,206
+25,722
| +82% | +$86.2K | ﹤0.01% | 3022 |
|
|
2022
Q4 | $151K | Buy |
31,484
+510
| +2% | +$2.45K | ﹤0.01% | 3099 |
|
|
2022
Q3 | $176K | Sell |
30,974
-235,604
| -88% | -$1.34M | ﹤0.01% | 2995 |
|
|
2022
Q2 | $1.89M | Buy |
266,578
+19,784
| +8% | +$140K | ﹤0.01% | 1793 |
|
|
2022
Q1 | $1.78M | Buy |
246,794
+173,579
| +237% | +$1.25M | ﹤0.01% | 1966 |
|
|
2021
Q4 | $654K | Sell |
73,215
-20,692
| -22% | -$185K | ﹤0.01% | 2657 |
|
|
2021
Q3 | $3.29M | Buy |
93,907
+55,150
| +142% | +$1.93M | ﹤0.01% | 1744 |
|
|
2021
Q2 | $833K | Buy |
38,757
+29,048
| +299% | +$624K | ﹤0.01% | 2871 |
|
|
2021
Q1 | $600K | Sell |
9,709
-885
| -8% | -$54.7K | ﹤0.01% | 2970 |
|
|
2020
Q4 | $443K | Buy |
+10,594
| New | +$443K | ﹤0.01% | 2965 |
|